VIDEX EC 125mg gastro-resistant capsules medication leaflet

J05AF02 didanosine • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Didanosine is an antiretroviral medication used to treat HIV-1 infection, usually in combination with other antiretroviral drugs. It belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs) and works by blocking the enzyme necessary for HIV replication.

The medication is taken orally, usually once or twice daily, on an empty stomach, as directed by a doctor.

Side effects may include nausea, diarrhea, abdominal pain, or peripheral neuropathy. In rare cases, severe adverse effects such as pancreatitis or lactic acidosis may occur.

Patients should strictly adhere to the treatment regimen prescribed by their doctor and undergo regular check-ups to monitor treatment effectiveness and safety. Pregnant or breastfeeding women should consult a specialist before use.

General data about VIDEX EC 125mg

Substance: didanosine

Date of last drug list: 01-07-2013

Commercial code: W10722002

Concentration: 125mg

Pharmaceutical form: gastro-resistant capsules

Quantity: 60

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for didanosine

Concentrations available for didanosine

100mg, 125mg, 150mg, 200mg, 250mg, 400mg